Listen "Avanos Medical sells respiratory health business, ResMed says PAP adherence reduces hospitalizations"
Episode Synopsis
Obvius Robotics' successful completion of the first human cases with the Certa access system represents a significant milestone for the company. Obvius Robotics' achievement highlights the ongoing progress in robotic-assisted surgery, where companies strive to develop solutions that improve surgical precision, reduce invasiveness, and minimize patient recovery time. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the technology and what doctors think about the technology.
The study supporting Imperative Care's stroke treatment offers valuable insights into improving patient outcomes in stroke care. By addressing the unique challenges of stroke care, Imperative Care aims to enhance the standard of care and improve patient prognosis. Whooley details the technology and some of the key data points from the study.
The partnership between AliveCor and Luscii to develop a 'heart clinic in a box' represents an exciting advancement in remote cardiac care. This collaboration aims to provide individuals with convenient and accessible tools for monitoring and managing their heart health from the comfort of their homes, potentially revolutionizing the delivery of cardiac care. Hear more about the partnership and how optimistic executives are at the two companies.
ResMed's PAP adherence study contributes to the growing body of evidence supporting the benefits of PAP therapy in sleep apnea management. It reinforces the need for healthcare professionals to educate patients about the importance of adherence to PAP therapy and highlights the potential impact on reducing healthcare costs and improving patient well-being. Get the full details of the study and the results in today's episode.
Avanos Medical's decision to sell its respiratory health business to SunMed reflects strategic moves within the medical device industry to optimize operations and focus on core areas of expertise. This transaction allows Avanos Medical to streamline its portfolio and allocate resources more efficiently. Whooley and Kirsh talk about the transaction and how Avanos Medical plans to use the proceeds from the sale.
Check out the show notes on MassDevice.com/podcast.
The study supporting Imperative Care's stroke treatment offers valuable insights into improving patient outcomes in stroke care. By addressing the unique challenges of stroke care, Imperative Care aims to enhance the standard of care and improve patient prognosis. Whooley details the technology and some of the key data points from the study.
The partnership between AliveCor and Luscii to develop a 'heart clinic in a box' represents an exciting advancement in remote cardiac care. This collaboration aims to provide individuals with convenient and accessible tools for monitoring and managing their heart health from the comfort of their homes, potentially revolutionizing the delivery of cardiac care. Hear more about the partnership and how optimistic executives are at the two companies.
ResMed's PAP adherence study contributes to the growing body of evidence supporting the benefits of PAP therapy in sleep apnea management. It reinforces the need for healthcare professionals to educate patients about the importance of adherence to PAP therapy and highlights the potential impact on reducing healthcare costs and improving patient well-being. Get the full details of the study and the results in today's episode.
Avanos Medical's decision to sell its respiratory health business to SunMed reflects strategic moves within the medical device industry to optimize operations and focus on core areas of expertise. This transaction allows Avanos Medical to streamline its portfolio and allocate resources more efficiently. Whooley and Kirsh talk about the transaction and how Avanos Medical plans to use the proceeds from the sale.
Check out the show notes on MassDevice.com/podcast.
More episodes of the podcast Fast Five Medtech News Podcast
Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent
15/03/2024
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
14/03/2024
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
12/03/2024
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
08/03/2024
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
06/03/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.